Core Viewpoint - The demand for global asset allocation is rising, with QDII funds showing strong performance, as 93% of them have achieved positive returns this year, particularly those focused on the Hong Kong pharmaceutical sector, with some funds exceeding 100% returns [1][2][4]. Group 1: QDII Fund Performance - As of the latest data, there are 314 QDII funds with a total size of 633.48 billion yuan, and 93% of these funds have achieved positive returns this year [1][2]. - The average returns for different types of QDII funds this year are as follows: mixed funds at 29%, stock funds at 22%, alternative investment funds at 17%, and bond funds at 3.6% [2]. - The top-performing QDII funds are primarily invested in the Hong Kong pharmaceutical sector, with the highest returns recorded at 142.57%, 107.47%, and 107.18% for specific funds [2][3]. Group 2: Market Trends and Drivers - The strong performance of Hong Kong stocks is attributed to three main factors: robust macroeconomic conditions in China, a subtle shift in the international environment, and the certainty of growth in specific sectors such as AI and innovative pharmaceuticals [4]. - The Hong Kong stock market has outperformed major global markets, driven by a rebound in the Hang Seng Index and the Hang Seng Tech Index [3][4]. Group 3: QDII Quota Expansion - The State Administration of Foreign Exchange has approved an additional QDII investment quota of 3.08 billion USD, bringing the total approved quota to 170.87 billion USD [5]. - There is a growing interest among institutions to apply for QDII qualifications, with 12 institutions currently in the application process, indicating a strong appetite for global asset allocation [5][6]. - Recent limitations on QDII fund subscriptions have been observed, as several funds have suspended or limited large subscriptions due to high demand exceeding the newly allocated quotas [6].
部分产品年内收益超140％！QDII基金亮眼 趁势扩容 多家机构排队入局
Sou Hu Cai Jing·2025-08-23 11:36